An increased ratio of dietary n-3 relative to
n-6 fatty acids has been shown to inhibit the development of
mammary cancer in animal models. However, the molecular mechanisms by which
n-3 fatty acids affect
tumor growth remain unknown. Here, we investigated the effects of varying dietary ratios of n-3:
n-6 fatty acids on cell signaling in a rat model of chemically induced mammary
carcinoma. Cell proliferation was reduced by 60% in
carcinomas from the high n-3:n-6 treatment group compared with the low n-3:n-6 treatment group. These changes were associated with decreased cyclin-D1 and phospho-
retinoblastoma protein expression and increased levels of
cyclin-dependent kinase inhibitors, CIP1 (p21) and KIP1 (p27). In addition, the apoptotic index was increased in
carcinomas from the high n-3:n-6 group and was associated with elevated
apoptotic protease-activating factor 1 and a higher ratio of Bax/Bcl-2. Interestingly, changes in
protein expression were consistent with reduced
inflammation and suppressed mTOR activity, and the molecular signature associated with high n-3:n-6 treatment revealed changes in PPARĪ³ activation and suppression of
lipid synthesis. Together, our findings indicate that the molecular effects of high dietary n-3 to n-6 ratios are heterogeneous in nature but point to consistent changes in lipid metabolism pathways, which may serve as potential therapeutic targets for
cancer prevention and control. This study identifies the pathways modulated by dietary
fatty acid ratios in a rat model of
breast cancer, with implications for
cancer prevention.